Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Male breast cancer: Opportunities for increased research funding and clinical trial access

Dr Oliver Bogler - MD Anderson Cancer Center, Houston, USA
Male breast cancer: Opportunities for increased research funding and clinical trial access ( Dr Oliver Bogler - MD Anderson Cancer Center, Houston, USA )
19 Dec 2013

Hypoxic metabolism in breast cancer: how to overcome resistance to anti-angiogenic therapy

Prof Adrian Harris - University of Oxford, Oxford, UK
Hypoxic metabolism in breast cancer: how to overcome resistance to anti-angiogenic therapy ( Prof Adrian Harris - University of Oxford, Oxford, UK )
19 Dec 2013

Adjuvant bisphosphonate therapy in breast cancer

Prof Michael Gnant - Medical University of Vienna, Vienna, Austria
Adjuvant bisphosphonate therapy in breast cancer ( Prof Michael Gnant - Medical University of Vienna, Vienna, Austria )
19 Dec 2013

Anastrozole cuts breast cancer cases by more than 50% in high risk women

Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK
Anastrozole cuts breast cancer cases by more than 50% in high risk women ( Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK )
18 Dec 2013

Long term use of aromatase inhibitors and compliance

Prof Peter Barrett-Lee - Cardiff University, UK
Long term use of aromatase inhibitors and compliance ( Prof Peter Barrett-Lee - Cardiff University, UK )
18 Dec 2013

PIK3CA gene mutations make HER2- and hormone receptor-positive breast cancers treatment-resistant

Prof Sibylle Loibl - German Breast Group, Neu-Isenburg, Germany
PIK3CA gene mutations make HER2- and hormone receptor-positive breast cancers treatment-resistant ( Prof Sibylle Loibl - German Breast Group, Neu-Isenburg, Germany )
16 Dec 2013

Anastrozole cuts breast cancer cases by more than 50% in high risk women

Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK
Anastrozole cuts breast cancer cases by more than 50% in high risk women ( Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK )
13 Dec 2013

Cancer cells and the immune system: a natural story?

Prof. Laurence Zitvogel - INSERM, Institut Gustave Roussy, Villejuif, France
Cancer cells and the immune system: a natural story? ( Prof. Laurence Zitvogel - INSERM, Institut Gustave Roussy, Villejuif, France )
3 Dec 2013

Immuno-Oncology: the next new paradigm in cancer treatment? Chairman's welcome and introduction

Prof. Winald Gerritsen - Radboud University Nijmegen Medical Centre, The Netherlands
Immuno-Oncology: the next new paradigm in cancer treatment? Chairman's welcome and introduction ( Prof. Winald Gerritsen - Radboud University Nijmegen Medical Centre, The Netherlands )
3 Dec 2013

Immuno-Oncology: a concept or already a reality?

Prof. Peter Johnson - Cancer Research UK Centre, University of Southampton, UK
Immuno-Oncology: a concept or already a reality? ( Prof. Peter Johnson - Cancer Research UK Centre, University of Southampton, UK )
3 Dec 2013

Why are Immuno-Oncology compounds different?

Prof. Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain
Why are Immuno-Oncology compounds different? ( Prof. Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain )
3 Dec 2013

The role of molecular pathways in therapeutic response and outcomes in breast cancer

Dr Fabrice André - Institut Gustave Roussy, Villejuif, France
The role of molecular pathways in therapeutic response and outcomes in breast cancer ( Dr Fabrice André - Institut Gustave Roussy, Villejuif, France )
8 Nov 2013